Cargando…
Antitumor Activity of TRAIL Recombinant Adenovirus in Human Malignant Glioma Cells
Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) has been reported to specifically kill malignant cells but to be relatively nontoxic to normal cells. One of disadvantages to previous in vivo protocols was the need for large quantities of TRAIL recombinant protein to suppress tumor gr...
Autores principales: | Kim, Ki-Uk, Seo, Su-Yeong, Heo, Ki-Young, Yoo, Young-Hyun, Kim, Hye-Jin, Lee, Hyeong-Sik, Choi, Sun-Seob, Hwang, Tae-Ho, Lee, Hye-Jeong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779307/ https://www.ncbi.nlm.nih.gov/pubmed/16361820 http://dx.doi.org/10.3346/jkms.2005.20.6.1046 |
Ejemplares similares
-
Possible Novel Therapy for Malignant Gliomas with Secretable Trimeric TRAIL
por: Jeong, Moonsup, et al.
Publicado: (2009) -
Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL
por: Kim, Hye Ryung, et al.
Publicado: (2012) -
Autophagic Inhibition via Lysosomal Integrity Dysfunction Leads to Antitumor Activity in Glioma Treatment
por: Hwang, Hui-Yun, et al.
Publicado: (2020) -
Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer
por: Jo, Min Jee, et al.
Publicado: (2020) -
Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect
por: Kim, Joo-Young, et al.
Publicado: (2017)